Literature DB >> 31741682

Optic Nerve Enhancement and Restricted Diffusion in Postoperative Visual Loss.

Pasquale F Finelli1.   

Abstract

Postoperative visual loss is rare and most often due to posterior ischemic optic neuropathy. We describe optic nerve MR imaging of a 37-year-old man with postoperative visual loss due to posterior ischemic optic neuropathy after complicated aortic aneurysm surgery. MR demonstrated restricted diffusion and focal enhancement of both optic nerves. Combined restricted diffusion and focal enhancement is a unique MR imaging feature with postoperative vision loss.
© 2018 Taylor & Francis Group, LLC.

Entities:  

Keywords:  MRI, diffusion; MRI, enhanced; Optic nerve; posterior ischemic optic neuropathy; postoperative vision loss; watershed

Year:  2018        PMID: 31741682      PMCID: PMC6844517          DOI: 10.1080/01658107.2018.1534126

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  5 in total

Review 1.  Using Diffusion-Weighted Magnetic Resonance Imaging to Confirm a Diagnosis of Posterior Ischaemic Optic Neuropathy: Two Case Reports and Literature Review.

Authors:  Ayyaz Quddus; Mitchell Lawlor; Ata Siddiqui; Paul Holmes; Gordon T Plant
Journal:  Neuroophthalmology       Date:  2015-06-23

2.  Perioperative visual loss in ocular and nonocular surgery.

Authors:  Kathleen T Berg; Andrew R Harrison; Michael S Lee
Journal:  Clin Ophthalmol       Date:  2010-06-24

Review 3.  Vision loss after spine surgery: review of the literature and recommendations.

Authors:  Mirza N Baig; Martin Lubow; Phillip Immesoete; Sergio D Bergese; Elsayed-Awad Hamdy; Ehud Mendel
Journal:  Neurosurg Focus       Date:  2007       Impact factor: 4.047

4.  Optic nerve enhancement in hypotensive ischemic optic neuropathy.

Authors:  Michael S Vaphiades
Journal:  J Neuroophthalmol       Date:  2004-09       Impact factor: 3.042

Review 5.  Acute visual loss with ophthalmoplegia after spinal surgery: report of a case and review of the literature.

Authors:  Bipasha Mukherjee; Mohammad Shahid Alam
Journal:  Indian J Ophthalmol       Date:  2014-09       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.